Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-26

Clinical Trial Update: A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of fasudil hydrochloride in combination with immunotherapy for metastatic castration-resistant pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fasudil Hydrochloride (fasudil hydrochloride)

Snippet

Sponsor: baotai Liang | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING